| 0 (0%) | 09-27 12:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 33.06 | 1-year : | 38.62 |
| Resists | First : | 28.3 | Second : | 33.06 |
| Pivot price | 27.79  |
|||
| Supports | First : | 27.5 | Second : | 27 |
| MAs | MA(5) : | 27.79 | MA(20) : | 27.74 |
| MA(100) : | 27.63 |
MA(250) : | 27.92  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 13.9 |
D(3) : | 36.7 |
| RSI | RSI(14): 47.4 | |||
| 52-week | High : | 29.89 | Low : | 25.95 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RESE ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 27.86 - 28 | 28 - 28.11 |
| Low: | 27.41 - 27.6 | 27.6 - 27.76 |
| Close: | 27.53 - 27.82 | 27.82 - 28.05 |
Sun, 14 Sep 2025
Football Recap: CHAR'rese BREVEARD Leads a Balanced Attack to Beat Northridge - MaxPreps.com
Wed, 03 Sep 2025
Cabaletta Bio Updates on Rese-cel Therapy Progress - TipRanks
Wed, 09 Jul 2025
Emergence of sliding ferroelectricity in naturally parallel-stacked multilayer ReSe2 semiconductor - Nature
Mon, 30 Jun 2025
Siegel's Rese Matthews, Riverdale's Parker Jones are 2025 DNJ President's Cup recipients - The Daily News Journal
Tue, 17 Jun 2025
CAR T-cell therapy rese-cel shows early efficacy in systemic sclerosis - Scleroderma News
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|